Company Filing History:
Years Active: 2001
Title: W Scott Borneman: Innovator in Bioprocess Technology
Introduction
W Scott Borneman is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of bioprocess technology, particularly in the production of dipeptide-based compounds. His innovative work has led to the development of a patented process that enhances the efficiency of bioprocesses in the pharmaceutical industry.
Latest Patents
W Scott Borneman holds a patent for a bioprocess for the production of dipeptide-based compounds. This patent outlines a method that involves the production of a recombinant polypeptide containing a dipeptide intermediate. The process further details how this intermediate can be processed to yield the final product, showcasing his expertise in biochemistry and biotechnology. He has 1 patent to his name.
Career Highlights
Borneman is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to apply his innovative ideas in a practical setting, contributing to advancements in drug development and production. His work is instrumental in improving the efficiency of bioprocesses, which is crucial for the pharmaceutical industry.
Collaborations
Throughout his career, W Scott Borneman has collaborated with esteemed colleagues, including Anil Goyal and Michael J Conder. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
W Scott Borneman's contributions to bioprocess technology exemplify the impact of innovation in the pharmaceutical industry. His patented processes and collaborative efforts continue to drive advancements in the production of essential compounds.